The histone deacetylase inhibitor PCI-24781 as a putative radiosensitizer in pediatric glioblastoma cell lines
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1475-2867
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
The histone deacetylase inhibitor PCI-24781 as a putative radiosensitizer in pediatric glioblastoma cell lines ; volume:16 ; number:1 ; day:18 ; month:4 ; year:2016 ; pages:1-11 ; date:12.2016
Cancer cell international ; 16, Heft 1 (18.4.2016), 1-11, 12.2016
- Creator
-
Andrade, Pamela Viani de
- Contributor
-
Andrade, Augusto Faria
Queiroz, Rosane Gomes de Paula
Scrideli, Carlos Alberto
Tone, Luiz Gonzaga
Valera, Elvis Terci
SpringerLink (Online service)
- DOI
-
10.1186/s12935-016-0306-5
- URN
-
urn:nbn:de:1111-20160420821
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:02 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Andrade, Pamela Viani de
- Andrade, Augusto Faria
- Queiroz, Rosane Gomes de Paula
- Scrideli, Carlos Alberto
- Tone, Luiz Gonzaga
- Valera, Elvis Terci
- SpringerLink (Online service)
Other Objects (12)
Senzitization of glioblastoma to TRAIL-induced apoptosis by histone deacetylase inhibitors
Enhanced efficacy of histone deacetylase inhibitor combined with bromodomain inhibitor in glioblastoma
Histone deacetylase 6 in cancer
Histone deacetylase inhibitors reverse resistance to methylating agents : mechanisms in malignant melanoma and glioblastoma cells
Histone deacetylase 3, not histone deacetylase 2, interacts with the major immediate early locus of human cytomegalovirus
Regulatory mechanisms of histone deacetylase 2 Sumoylation
Role of histone deacetylase 11 in neuroblastoma
Dendritic cell development requires histone deacetylase activity
Limited proteolysis of human histone deacetylase 1
Development of class IIa histone deacetylase inhibitors
Histone Deacetylase Expressions in Hepatocellular Carcinoma and Functional Effects of Histone Deacetylase Inhibitors on Liver Cancer Cells In Vitro
Nitric oxide affects histone acetylation by inhibiting histone deacetylase activity in Arabidopsis
Senzitization of glioblastoma to TRAIL-induced apoptosis by histone deacetylase inhibitors
Enhanced efficacy of histone deacetylase inhibitor combined with bromodomain inhibitor in glioblastoma
Histone deacetylase 6 in cancer
Histone deacetylase inhibitors reverse resistance to methylating agents : mechanisms in malignant melanoma and glioblastoma cells
Histone deacetylase 3, not histone deacetylase 2, interacts with the major immediate early locus of human cytomegalovirus
Regulatory mechanisms of histone deacetylase 2 Sumoylation
Role of histone deacetylase 11 in neuroblastoma
Dendritic cell development requires histone deacetylase activity
Limited proteolysis of human histone deacetylase 1
Development of class IIa histone deacetylase inhibitors
Histone Deacetylase Expressions in Hepatocellular Carcinoma and Functional Effects of Histone Deacetylase Inhibitors on Liver Cancer Cells In Vitro
Nitric oxide affects histone acetylation by inhibiting histone deacetylase activity in Arabidopsis
Senzitization of glioblastoma to TRAIL-induced apoptosis by histone deacetylase inhibitors
Enhanced efficacy of histone deacetylase inhibitor combined with bromodomain inhibitor in glioblastoma
Histone deacetylase 6 in cancer
Histone deacetylase inhibitors reverse resistance to methylating agents : mechanisms in malignant melanoma and glioblastoma cells
Histone deacetylase 3, not histone deacetylase 2, interacts with the major immediate early locus of human cytomegalovirus
Regulatory mechanisms of histone deacetylase 2 Sumoylation
Role of histone deacetylase 11 in neuroblastoma
Dendritic cell development requires histone deacetylase activity
Limited proteolysis of human histone deacetylase 1
Development of class IIa histone deacetylase inhibitors
Histone Deacetylase Expressions in Hepatocellular Carcinoma and Functional Effects of Histone Deacetylase Inhibitors on Liver Cancer Cells In Vitro